Melanotan 2 Dosage: How Much to Take, When & How

Melanotan 2 Dosage: How Much to Take, When & How

Overview

Melanotan 2 (MT-II) is a synthetic peptide that mimics alpha-melanocyte-stimulating hormone, originally developed to induce skin tanning without UV exposure. It acts as a non-selective agonist at melanocortin receptors throughout the body, triggering effects ranging from skin pigmentation to appetite suppression and sexual function enhancement.

Critical Safety Note: Melanotan 2 is not FDA or EMA approved for any medical use and is sold exclusively as a research chemical. It is a controlled or restricted substance in the UK, Australia, Canada, and other jurisdictions. This guide is educational only and does not constitute medical advice. Consult a physician before use.

The most serious concern with MT-II is its potential to stimulate growth or transformation of melanocytic nevi, raising unresolved questions about melanoma risk. Users should undergo regular dermatological screening, and individuals with a personal or family history of melanoma or dysplastic nevi should avoid use entirely.

Standard Dosing Protocol

Melanotan 2 is administered via two primary routes: injection (subcutaneous) or nasal. Each route has distinct dosing guidelines.

Injection Protocol (Subcutaneous)

Loading Phase:

• Dose: 0.25–0.5 mg once daily
• Duration: 7–14 days
• Purpose: Establish baseline pigmentation and assess tolerance
• Administration: Single subcutaneous injection, typically in the abdomen or thigh

Maintenance Phase:

• Dose: Same as loading phase (0.25–0.5 mg per injection)
• Frequency: 2–3 times per week
• Duration: Ongoing, as desired
• Timing: Maintain consistent intervals (e.g., Monday, Wednesday, Friday)

Total Monthly Cost: $25–$80, depending on source and purity

Nasal Protocol

Standard Dosing:

• Dose: 0.5–1 mg per dose
• Frequency: Once daily
• Administration: Intranasal spray or powder insufflation
• Onset: Slower than injection; effects accumulate over days

Nasal administration offers convenience but typically produces weaker and less consistent results compared to injection due to absorption variability.

Dosing by Goal

Different objectives require different dosing strategies and durations.

Skin Tanning & Pigmentation

Beginner:

• Loading: 0.25 mg daily × 7–10 days
• Maintenance: 0.25 mg, 2× per week
• Expected timeline: Visible pigmentation in 10–14 days
• Endpoint: Stop when desired tan is achieved; resume 1× monthly to maintain

Experienced Users:

• Loading: 0.5 mg daily × 10–14 days
• Maintenance: 0.5 mg, 2–3× per week
• Expected timeline: Rapid pigmentation within 5–7 days
• Endpoint: Maintain indefinitely at lower frequency (1× per week)

Critical Warning: MT-II stimulates darkening and proliferation of existing moles. The risk of melanoma or dysplastic nevi transformation is serious. Discontinue immediately if new or changing lesions appear, and seek dermatological evaluation.

Erectile Dysfunction & Sexual Enhancement

Standard Dosing:

• Dose: 0.025 mg/kg body weight per injection (approximately 2–3 mg for an 80–100 kg male)
• Frequency: As needed, or every 48–72 hours for sustained enhancement
• Onset: 30–120 minutes post-injection
• Duration: 4–6 hours of heightened sexual function

Note: Clinical trials showed efficacy in 85% of men with psychogenic or organic ED at this dosing. However, priapism risk increases at higher doses—do not exceed 0.05 mg/kg per injection.

Appetite Suppression & Fat Loss

Loading Phase:

• Dose: 0.25–0.5 mg daily
• Duration: 7–14 days
• Expected effect: Reduced hunger within 24–48 hours

Maintenance:

• Dose: 0.25–0.5 mg, 2–3× per week
• Purpose: Sustained appetite suppression without daily dosing

Expected Outcomes: Animal models demonstrate consistent fat mass reduction. However, no human clinical trials exist. Efficacy in humans is unproven, and effects may be modest.

Mood, Stress, & Neuroprotection

Research-Level Dosing:

• Dose: 0.25–0.5 mg, 2–3× per week
• Duration: Minimum 4–8 weeks for measurable mood effects
• Rationale: Animal studies show antidepressant effects and BDNF elevation in chronically stressed rodents

Important: Evidence is limited to animal models. No human trials demonstrate efficacy for mood or stress.

How to Administer

Injection Technique (Subcutaneous)

Equipment:

• Sterile insulin syringe (29–31 gauge)
• Alcohol wipes
• Research-grade MT-II powder or liquid
• Bacteriostatic water for reconstitution (if powder)

Steps:

1. Reconstitution (if powder):

   • Draw bacteriostatic water into syringe
   • Inject into vial of MT-II powder
   • Allow 2–5 minutes for dissolution
   • Gently shake (do not vigorous shake)

2. Preparation:

   • Wipe injection site with alcohol pad
   • Allow to air-dry (30 seconds minimum)
   • Pinch skin slightly to create a subcutaneous pocket

3. Injection:

   • Insert needle at 45–90 degree angle into pinched skin
   • Inject slowly (5–10 seconds) to minimize tissue trauma
   • Withdraw needle and apply light pressure with clean pad

4. Storage:

   • Reconstituted solution: Refrigerate at 2–8°C, use within 2–4 weeks
   • Powder: Store at room temperature, protected from light

Common Sites: Lower abdomen, outer thigh, upper arm (rotate to prevent lipohypertrophy)

Nasal Administration

Method:

• Dissolve MT-II powder in bacteriostatic water (concentration: 2–5 mg/mL)
• Transfer to nasal spray bottle or use powder insufflation with specialized applicator
• Administer 0.5–1 mg per nostril once daily

• Onset slower (6–12 hours) than injection

Disadvantage: Nasal mucosa absorption is unpredictable; effects are often weaker and inconsistent compared to injection.

Cycling & Timing

Loading-Maintenance Cycle

Week 1–2 (Loading):

• 0.25–0.5 mg daily
• Observe tolerance, side effects, and pigmentation response
• Do not increase dose during this phase

Week 3 Onward (Maintenance):

• Reduce to 2–3 injections per week
• Space doses 48–72 hours apart (e.g., Mon/Wed/Fri)
• Maintain skin pigmentation and desired effects

Seasonal Adjustment

High-Sun Season (Summer):

• Reduce frequency to 1× per week or pause entirely
• Natural UV exposure maintains pigmentation
• Resume at 2× per week when sun exposure decreases

Low-Sun Season (Winter):

• Increase to 2–3× per week
• Maintain baseline pigmentation
• Reduce after pigmentation plateaus

Break Cycling (Optional)

Rationale: Long-term continuous use has not been studied in humans. Some users implement periodic breaks to reduce systemic exposure and melanoma risk.

Example Protocol:

• Use for 12 weeks
• Break for 4–8 weeks
• Resume if desired effects wane
• Monitor moles closely during and after breaks

Beginner vs. Advanced Dosing

Beginner Protocol

Week 1–2:

• Start: 0.25 mg daily (subcutaneous injection)
• Assess: Tolerance, nausea, side effects, pigmentation
• Do not advance dose if side effects occur

Week 3–4:

• Reduce to 0.25 mg, 2× per week (e.g., Mon/Thu)
• Maintain this dose for 8–12 weeks
• Evaluate pigmentation; if insufficient, increase to 0.5 mg at next injection

Advantages:

• Minimizes nausea and systemic side effects
• Lower total monthly dose (~$25–$35)
• Allows safer assessment of individual tolerance

Advanced Protocol

Week 1–2:

• Start: 0.5 mg daily
• Anticipate: Higher nausea risk (first 30–60 minutes); take anti-nausea medication if needed
• Tolerance: Nausea typically subsides after 3–5 injections

Week 3–4:

• Reduce to 0.5 mg, 3× per week (e.g., Mon/Wed/Fri)
• Rapidly achieves maximal pigmentation (within 7–10 days total)
• Sustains darkened skin with high-frequency maintenance

Week 5+:

• Consider dose reduction to 0.25 mg, 2–3× per week once pigmentation plateau is reached
• Or maintain 0.5 mg, 1–2× per week

Advantages:

• Faster results (5–7 days to visible tan)
• Higher receptor saturation
• Greater appetite suppression and sexual function effects

Disadvantages:

• Increased side effects (nausea, flushing, spontaneous erections)
• Higher cost (~$50–$80/month)
• Potentially higher melanoma risk with cumulative high-dose exposure

Common Dosing Mistakes

1. Exceeding 0.05 mg/kg per injection: Priapism risk increases significantly above this threshold. Do not exceed 0.5 mg for most individuals.

2. Daily dosing beyond loading phase: Continuing 0.25–0.5 mg daily after week 2 leads to unnecessary systemic exposure and side effects without additional benefit.

3. Skipping dermatological screening: Moles can darken and transform rapidly. Schedule a full-body skin exam before starting, monthly during loading, and every 3 months during maintenance.

4. Ignoring nasal absorption variability: Nasal dosing produces inconsistent effects. Injection is far more reliable for consistent results.

5. Not spacing injections adequately: Dosing more than 3× per week (beyond loading phase) increases toxicity risk without additional pigmentation benefit.

6. Mixing routes unpredictably: Alternating between injection and nasal without accounting for dose conversion creates overdosing risk. Choose one route and remain consistent.

7. Continuing use with changing moles: Any new mole or rapid change in existing moles warrants immediate discontinuation and dermatological evaluation.

8. Poor injection site rotation: Repeated injections in the same location cause lipohypertrophy and uneven absorption. Rotate sites systematically.

Summary Table: Melanotan 2 Dosing Reference

Final Guidance

Melanotan 2 dosing requires careful individualization based on body weight, tolerance, and specific goals. The standard injection loading protocol of 0.25–0.5 mg daily for 7–14 days, followed by 2–3× weekly maintenance, remains the most evidence-supported approach.

Critical safeguards:

• Obtain dermatological baseline and monthly screening
• Avoid use if personal or family history of melanoma exists
• Discontinue immediately if new or changing moles appear
• Stay within 0.05 mg/kg per injection maximum
• Do not continue daily dosing beyond loading phase
• Monitor for priapism, nausea, and systemic side effects

Cost ranges from $25–$80 per month depending on dose and frequency. Results are highly individual, and human efficacy data exist only for sexual function and skin tanning—both carry significant safety concerns that must be weighed carefully.

This guide is educational only and does not constitute medical or legal advice. Melanotan 2 regulatory status varies by jurisdiction. Consult a qualified healthcare provider before use.